310 related articles for article (PubMed ID: 34375485)
1. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia.
Silva-Spínola A; Lima M; Leitão MJ; Durães J; Tábuas-Pereira M; Almeida MR; Santana I; Baldeiras I
Eur J Neurol; 2022 Jan; 29(1):36-46. PubMed ID: 34375485
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
3. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
Giuffrè GM; Quaranta D; Costantini EM; Citro S; Martellacci N; De Ninno G; Vita MG; Guglielmi V; Rossini PM; Calabresi P; Marra C
Neurobiol Dis; 2023 Oct; 186():106267. PubMed ID: 37652185
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
[TBL] [Abstract][Full Text] [Related]
6. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
[TBL] [Abstract][Full Text] [Related]
8. Blood Neurofilament Light Chain in Different Types of Dementia.
Gu L; Shu H; Wang Y; Wang P
Curr Alzheimer Res; 2023; 20(3):149-160. PubMed ID: 37264656
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
11. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
[TBL] [Abstract][Full Text] [Related]
12. Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia.
Giannini LAA; Seelaar H; van der Ende EL; Poos JM; Jiskoot LC; Dopper EGP; Pijnenburg YAL; Willemse EAJ; Vermunt L; Teunissen CE; van Swieten JC; Meeter LH
Neurology; 2023 Sep; 101(10):e1069-e1082. PubMed ID: 37491327
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
[TBL] [Abstract][Full Text] [Related]
15. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
[TBL] [Abstract][Full Text] [Related]
17. Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia.
Das S; Goossens J; Jacobs D; Dewit N; Pijnenburg YAL; In 't Veld SGJG; Teunissen CE; Vanmechelen E
Alzheimers Res Ther; 2023 Mar; 15(1):62. PubMed ID: 36964594
[TBL] [Abstract][Full Text] [Related]
18. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.
Sjögren M; Rosengren L; Minthon L; Davidsson P; Blennow K; Wallin A
Neurology; 2000 May; 54(10):1960-4. PubMed ID: 10822437
[TBL] [Abstract][Full Text] [Related]
19. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
[TBL] [Abstract][Full Text] [Related]
20. CSF neurofilament light concentration is increased in presymptomatic
Rostgaard N; Roos P; Portelius E; Blennow K; Zetterberg H; Simonsen AH; Nielsen JE
Neurology; 2018 Jan; 90(2):e157-e163. PubMed ID: 29237796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
